Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
1.070
-0.070 (-6.14%)
Jul 9, 2026, 3:43 PM EST
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 19 employees as of March 31, 2026. The number of employees decreased by 10 or -34.48% compared to the same quarter last year.
Employees
19
Change
-10
Growth
-34.48%
Revenue / Employee
n/a
Profits / Employee
-$503,684
Market Cap
11.81M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| Oncotelic Therapeutics | 43 |
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| Anebulo Pharmaceuticals | 3 |
| Galera Therapeutics | 3 |
Brainstorm Cell Therapeutics News
- 5 weeks ago - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PRNewsWire
- 6 weeks ago - Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TheFly
- 6 weeks ago - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors - PRNewsWire
- 7 weeks ago - Brainstorm Cell Therapeutics Registration statement: Registration filing - Filings
- 7 weeks ago - BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market - PRNewsWire
- 7 weeks ago - BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Brainstorm Cell Therapeutics Earnings release: Q1 2026 - Filings